ABHD2 and ovarian carcinoma: In summary, altered ABHD2, ELAC2 and CYB5R3 mRNA expression was identified through our functional genomics screen and was significantly reduced in ovarian cancer, especially in HGSOC, relative to that in SBT or normal ovarian epithelium.